Zai Lab (ZLAB) Cash from Operations (2020 - 2026)
Zai Lab's (ZLAB) quarterly Cash from Operations came in at 11912000.0 in Q1 2026, up 80.69% year-on-year from 6592383.69 in Q1 2025, and up 54.22% quarter-over-quarter from 26022000.0 in Q4 2025.
Zai Lab (ZLAB) Cash from Operations (2020 - 2026) Analysis & Trends
Zai Lab has disclosed Cash from Operations across 7 years of filings, most recently posting 11912000.0 for Q1 2026.
- Cash from Operations for Q1 2026 came in at 11912000.0, up 80.69% year-over-year; the trailing twelve-month figure through Mar 2026 was 101002000.0 (up 45.83% YoY), and the FY2025 annual result was 150789000.0, up 29.82% from the prior year.
- Cash from Operations came in at 11912000.0 for Q1 2026 at Zai Lab, up from 26022000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 11912000.0 in Q1 2026 to a low of 126323000.0 in Q3 2022.
- The 5-year median for Cash from Operations is 55272000.0 (2023), against an average of 55493529.41.
- Across the five-year window, Cash from Operations surged 86.35% in 2023 and tumbled 273.86% in 2024, its largest moves.
- Zai Lab's Cash from Operations stood at 109292000.0 in 2022, then soared by 86.35% to 14917000.0 in 2023, then sank by 273.86% to 55769000.0 in 2024, then surged by 53.34% to 26022000.0 in 2025, then surged by 54.22% to 11912000.0 in 2026.
- The last three Cash from Operations figures came in at 11912000.0 (Q1 2026), 26022000.0 (Q4 2025), and 32044000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Zai Lab | 20.15 Bn | 20.05 Bn | 61.30 Mn | -11.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.91 Mn |
| Mar 31, 2026 | -11.91 Mn |
| Dec 31, 2025 | -26.02 Mn |
| Dec 31, 2025 | -26.02 Mn |
| Sep 30, 2025 | -32.04 Mn |
| Sep 30, 2025 | -32.04 Mn |
| Jun 30, 2025 | -31.02 Mn |
| Jun 30, 2025 | -31.02 Mn |
| Mar 31, 2025 | -61.70 Mn |
| Mar 31, 2025 | -61.70 Mn |
| Dec 31, 2024 | -55.77 Mn |
| Dec 31, 2024 | -55.77 Mn |
| Sep 30, 2024 | -26.82 Mn |
| Sep 30, 2024 | -26.82 Mn |
| Jun 30, 2024 | -42.17 Mn |
| Jun 30, 2024 | -42.17 Mn |
| Mar 31, 2024 | -90.11 Mn |
| Mar 31, 2024 | -90.11 Mn |
| Dec 31, 2023 | -14.92 Mn |
| Dec 31, 2023 | -14.92 Mn |